PROSION Therapeutics

📍 Cologne, Germany🗓 Founded 2020👥 10 employees💰 Last funded May 2022
Biotechnology Research🌐 prosion.eu
Website LinkedIn
We are PROSION Therapeutics, a biotech & drug development company based in Germany that aims at making the undruggable druggable. Through our proprietary platform technology of LEGO-like chemical building blocks, we are able to develop new and effective drugs, targeting hard-to-treat diseases - starting with the most aggressive cancer forms.
3
Total investors
3
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Germany
3
Frequently asked questions
Who invested in PROSION Therapeutics?
PROSION Therapeutics has 3 investors on record on gritt.io, including 3 early-stage backers.
When did PROSION Therapeutics last raise funding?
The most recent investment in PROSION Therapeutics recorded on gritt.io was in May 2022.
When was PROSION Therapeutics founded?
PROSION Therapeutics was founded in 2020.
What industry is PROSION Therapeutics in?
PROSION Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is PROSION Therapeutics based?
PROSION Therapeutics is headquartered in Cologne, Germany.